Spinomix (FibroTrap sample processing technology) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Spinomix (FibroTrap sample processing technology) General Information
Description
FibroTrap is a fibrinogen based sample processing technology. The technology is used for separation and concentration of target molecules from liquid samples within a simple, routine sample-collection tube. It is applicable to a wide variety of matrices such as blood, urine, swabs and food to isolate a large spectrum of targets such as bacteria, viruses and tumor cells and hence provides a breakthrough in sample processing applied to clinical diagnostics and the food industry.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Debiopharm Group
Primary Office
- Innovation Square EPFL PSE-A
- 1015 Lausanne
- Switzerland
Spinomix (FibroTrap sample processing technology) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Spinomix (FibroTrap sample processing technology) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|